Does Self-Efficacy Affect Cognitive Performance in Persons with Clinically Isolated Syndrome and Early Relapsing Remitting Multiple Sclerosis?. (29th April 2015)

• Record Type: Journal Article
• Authors: Jongen, Peter Joseph; Wesnes, Keith; van Geel, Björn; Pop, Paul; Schrijver, Hans; Visser, Leo H.; Gilhuis, H. Jacobus; Sinnige, Ludovicus G.; Brands, Augustina M.
• Other Names: Ghezzi Angelo Academic Editor.
• Is Part Of: Multiple sclerosis international. Volume 2015(2015)
• Publication Date: 2015-04-29
• Subjects: Multiple sclerosis -- Periodicals; 616.834005
• DOI: 10.1155/2015/960282
• Languages: English
• ISSNs: 2090-2654

Abstract

Abstract : In persons with multiple sclerosis (MS) a lowered self-efficacy negatively affects physical activities. Against this background we studied the relationship between self-efficacy and cognitive performance in the early stages of MS. Thirty-three patients with Clinically Isolated Syndrome (CIS) and early Relapsing Remitting MS (eRRMS) were assessed for self-efficacy (MSSES-18), cognition (CDR System), fatigue (MFIS-5), depressive symptoms (BDI), disease impact (MSIS-29), and disability (EDSS). Correlative analyses were performed between self-efficacy and cognitive scores, and stepwise regression analyses identified predictors of cognition and self-efficacy. Good correlations existed between total self-efficacy and Power of Attention (r = 0.65 ;P < 0.001 ), Reaction Time Variability (r = 0.57 ;P < 0.001 ), and Speed of Memory (r = 0.53 ;P < 0.01 ), and between control self-efficacy and Reaction Time Variability (r = 0.55 ;P < 0.01 ). Total self-efficacy predicted 40% of Power of Attention, 34% of Reaction Time Variability, and 40% of Speed of Memory variabilities. Disease impact predicted 65% of total self-efficacy and 58% of control self-efficacy variabilities. The findings may suggest that in persons with CIS and eRRMS self-efficacy may positively affect cognitive performance and that prevention of disease activity may preserve self-efficacy.